---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-22-007357"
form_type: "8-K"
ticker: "AGPU"
cik: "0001446159"
company_name: "Axe Compute Inc."
filed_at: "2022-11-10T23:59:59+00:00"
generated_at: "2026-06-21T22:41:18.987353+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Predictive Oncology receives Nasdaq extension to May 8, 2023 to meet $1 bid price rule

## Summary
- Nasdaq granted a 180-day extension until May 8, 2023 for the company to regain compliance with the $1 minimum bid price rule.
- Company still not in compliance; had previously received a deficiency notice on May 13, 2022.
- To cure, the company may effect a reverse stock split; failure could lead to delisting and an appeal.
- Extension conditional on meeting all other Nasdaq listing requirements; company currently meets those.

## SEC filing metadata
- accession: 0001171843-22-007357
- form_type: 8-K
- ticker: AGPU
- cik: 0001446159
- company_name: Axe Compute Inc.
- filed_at: 2022-11-10T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446159/000117184322007357/0001171843-22-007357-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446159/000117184322007357/f8k_111022.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-22-007357
- JSON: https://secwatch.observer/filing/0001171843-22-007357.json
- Plain text: https://secwatch.observer/filing/0001171843-22-007357.txt

## Key facts
- Listing & Compliance Notices
  Axe Compute Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: November 10, 2022, Nasdaq notified the Company that while the Company had not regained compliance with the Minimum Bid Price Requirement, it is eligible for an additional 180-day calendar period, or until May 8, 2023, to regain compliance. Nasdaq’s determination was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and the Company’s written notice to Nasdaq of its intention to cure the deficiency d
  evidence_url: https://www.sec.gov/Archives/edgar/data/1446159/000117184322007357/0001171843-22-007357-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.